ICU
Income statement / Annual
Last year (2023), SeaStar Medical Holding Corporation's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, SeaStar Medical Holding Corporation's net income was -$26.23 M.
See SeaStar Medical Holding Corporation�s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$5.97 M
|
$2.82 M
|
$2.77 M
|
$4.03 M
|
| General & Administrative
Expenses |
$8.01 M
|
$6.60 M
|
$1.68 M
|
$2.43 M
|
| Selling & Marketing
Expenses |
$32,000.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$8.04 M
|
$6.60 M
|
$1.68 M
|
$2.43 M
|
| Other Expenses |
$200,000.00 |
$0.00 |
$91,000.00 |
$84,000.00 |
| Operating Expenses |
$14.21 M |
$11.61 M |
$4.45 M |
$6.45 M |
| Cost And Expenses |
$14.21 M |
$11.61 M |
$4.45 M |
$6.45 M |
| Interest Income |
$0.00 |
$630.00 |
$212.00 |
$3,308.00 |
| Interest Expense |
$1.08 M |
$630,000.00 |
$212,000.00 |
$3.31 M |
| Depreciation &
Amortization |
$14.01 M
|
$11.61 M
|
$4.45 M
|
$6.45 M
|
| EBITDA |
-$11.14 M
|
-$11.61 M
|
$0.00
|
$0.00
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$12.02 M
|
-$11.40 M
|
-$148,000.00
|
$3.19 M
|
| Income Before Tax |
-$26.23 M |
-$23.01 M |
-$4.60 M |
-$3.27 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
$1,000.00 |
-$1,000.00 |
$9,000.00 |
| Net Income |
-$26.23 M |
-$23.01 M |
-$4.60 M |
-$3.28 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
| EPS |
-30.29 |
-70.16 |
-15.9 |
-27.15 |
| EPS Diluted |
-30.26 |
-70.07 |
-15.87 |
-27.15 |
| Weighted Average Shares
Out |
$866,000.00
|
$328,000.00
|
$289,000.00
|
$120,670.00
|
| Weighted Average Shares
Out Diluted |
$866,813.00
|
$328,450.00
|
$289,551.00
|
$120,670.00
|
| Link |
|
|
|
|
